Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07451496Not ApplicableRecruiting

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

Role: collaborator

NCT06990256Not ApplicableRecruiting

Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers

Role: collaborator

NCT06629636Not ApplicableRecruiting

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Role: collaborator

NCT04823260Not ApplicableCompleted

To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults

Role: lead

All 4 trials loaded